Homology modeling of lanosterol 14alpha-demethylase of Candida albicans and Aspergillus fumigatus and insights into the enzyme-substrate Interactions
- PMID: 15214809
- DOI: 10.1080/07391102.2004.10506984
Homology modeling of lanosterol 14alpha-demethylase of Candida albicans and Aspergillus fumigatus and insights into the enzyme-substrate Interactions
Abstract
The crystal structure of 14alpha-sterol demethylase from Mycobacterium tuberculosis (MT_14DM) provides a good template for modeling the three dimensional structure of lanosterol 14alpha-demethylase, which is the target of azole antifungal agents. Homologous 3D models of lanosterol 14alpha-demethylase from Candida albicans (CA_14DM) and Aspergillus fumigatus (AF_14DM) were built on the basis of the crystal coordinates of MT_14DM in complex with 4-phenylimidazole and fluconazole. The reliability of the two models was assessed by Ramachandran plots, Profile-3D analysis, and by analyzing the consistency of the two models with the experimental data on the P450(14DM). The overall structures of the resulting CA_14DM model and AF_14DM model are similar to those of the template structures. The two models remain the core structure characteristic for cytochrome P450s and most of the insertions and deletions expose the molecular surface. The structurally and functionally important residues such as the heme binding residues, the residues lining the substrate access channel, and residues in active site were identified from the model. To explore the binding mode of the substrate with the two models, 24(28)-methylene-24,25-dihydrolanosterol was docked into the active site of the two models and hydrophobic interaction and hydrogen-bonding were found to play an important role in substrate recognition and orientation. These results provided a basis for experiments to probe structure-function relationships in the P450(14DM). Although CA_14DM and AF_14DM shared similar core structural character, the active site of the two models were quite different, thus allowing the rational design of specific inhibitors to the target enzyme and the discovery of novel antifungal agents with broad spectrum.
Copyright 2004 Adenine Press
Similar articles
-
A three-dimensional model of lanosterol 14alpha-demethylase of Candida albicans and its interaction with azole antifungals.J Med Chem. 2000 Jun 29;43(13):2493-505. doi: 10.1021/jm990589g. J Med Chem. 2000. PMID: 10891108
-
Modeling and interactions of Aspergillus fumigatus lanosterol 14-alpha demethylase 'A' with azole antifungals.Bioorg Med Chem. 2004 Jun 1;12(11):2937-50. doi: 10.1016/j.bmc.2004.03.034. Bioorg Med Chem. 2004. PMID: 15142553
-
Crystal structure of cytochrome P450 14alpha -sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors.Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3068-73. doi: 10.1073/pnas.061562898. Proc Natl Acad Sci U S A. 2001. PMID: 11248033 Free PMC article.
-
Cytochrome P450 lanosterol 14α-demethylase (CYP51): insights from molecular genetic analysis of the ERG11 gene in Saccharomyces cerevisiae.J Steroid Biochem Mol Biol. 1992 Dec;43(8):1107-16. doi: 10.1016/0960-0760(92)90339-K. J Steroid Biochem Mol Biol. 1992. PMID: 22217856 Review.
-
Sterol 14 alpha-demethylase and its inhibition: structural considerations on interaction of azole antifungal agents with lanosterol 14 alpha-demethylase (P-450(14DM)) of yeast.Biochem Soc Trans. 1991 Aug;19(3):778-82. doi: 10.1042/bst0190778. Biochem Soc Trans. 1991. PMID: 1783215 Review. No abstract available.
Cited by
-
Evolutionary trace analysis of CYP51 family: implication for site-directed mutagenesis and novel antifungal drug design.J Mol Model. 2010 Feb;16(2):279-84. doi: 10.1007/s00894-009-0527-9. Epub 2009 Jul 11. J Mol Model. 2010. PMID: 19593597
-
X-ray structure of 4,4'-dihydroxybenzophenone mimicking sterol substrate in the active site of sterol 14alpha-demethylase (CYP51).J Biol Chem. 2008 May 30;283(22):15152-9. doi: 10.1074/jbc.M801145200. Epub 2008 Mar 26. J Biol Chem. 2008. PMID: 18367444 Free PMC article.
-
Amino acid substitutions at the major insertion loop of Candida albicans sterol 14alpha-demethylase are involved in fluconazole resistance.PLoS One. 2011;6(6):e21239. doi: 10.1371/journal.pone.0021239. Epub 2011 Jun 16. PLoS One. 2011. PMID: 21698128 Free PMC article.
-
The protein farnesyltransferase inhibitor Tipifarnib as a new lead for the development of drugs against Chagas disease.J Med Chem. 2005 Aug 25;48(17):5415-8. doi: 10.1021/jm050441z. J Med Chem. 2005. PMID: 16107140 Free PMC article.
-
Identification of 1, 2, 4-Triazine and Its Derivatives Against Lanosterol 14-Demethylase (CYP51) Property of Candida albicans: Influence on the Development of New Antifungal Therapeutic Strategies.Front Med Technol. 2022 Mar 28;4:845322. doi: 10.3389/fmedt.2022.845322. eCollection 2022. Front Med Technol. 2022. PMID: 35419560 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources